MedAware

MedAwareMedAware
MedAware

MedAware

MedAware provides AI-driven clinical decision support to prevent medication-related errors in healthcare.

DR 32Speed 982012Active9Tel Aviv, Israel
Rate

About

MedAware develops an AI-powered clinical decision support system that analyzes vast amounts of medical data to identify and prevent medication-related errors in real-time. Their solution helps healthcare providers avoid adverse drug events, improve patient safety, and reduce healthcare costs by flagging potential issues before they occur.
Frequently asked

What does MedAware do?

MedAware develops an AI-powered clinical decision support system that analyzes vast amounts of medical data to identify and prevent medication-related errors in real-time. Their solution helps healthcare providers avoid adverse drug events, improve patient safety, and reduce healthcare costs by flagging potential issues before they occur.

What is MedAware's valuation?

StartupHub estimates MedAware's effective valuation at $141.7M (range $89.0M to $213.6M, 10% confidence), based on comparable companies in the sector.

How much funding has MedAware raised?

MedAware has raised a total of $36M in funding. The most recent round on record is Series A.

Where is MedAware headquartered?

MedAware is headquartered in Tel Aviv, Israel.

When was MedAware founded?

MedAware was founded in 2012.

What industry does MedAware operate in?

MedAware operates in Prevention, Healthcare, Prescription Errors, Prescription, Patient Safety, Medication Errors.

How many employees does MedAware have?

MedAware has approximately 9 people on record.

HEADCOUNT
9
DOMAIN RATING
32
New entrants in Healthcare
Last 90 days
2
New entrants
0.7
Per month
0.2
Per week

An entrant is a company tagged Healthcare whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.

Comments

No comments yet. Be the first to share your take.